Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study-Reference-Cited by-同舟云学术

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Published:2012-03-27 Issue:4 Volume:64 Page:1215-1226
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Rovin Brad H.,Furie Richard,Latinis Kevin,Looney R. John,Fervenza Fernando C.,Sanchez-Guerrero Jorge,Maciuca Romeo,Zhang David,Garg Jay P.,Brunetta Paul,Appel Gerald,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference52 articles.

1. Updates on the treatment of lupus nephritis;Bomback;J Am Soc Nephrol,2010

2. Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option;McKinley;Clin J Am Soc Nephrol,2009

3. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide;Houssiau;Arthritis Rheum,2002

4. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis: a randomized controlled trial;Grootscholten;Kidney Int,2006

5. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis;Ginzler;N Engl J Med,2005

Cited by 1123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cells and generation of antibodies;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Future directions;Dubois' Lupus Erythematosus and Related Syndromes;2025

3. Management of lupus nephritis;Dubois' Lupus Erythematosus and Related Syndromes;2025

4. Targeted therapies in SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

5. CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy;Joint Bone Spine;2024-09